The unexpected outbreak of COVID-19 has significantly affected the global marketplace. As a result, transfer pricing issues are emerging that should be proactively considered.
Some common transfer pricing issues companies are addressing during this period of disruption are:
- Financial transactions
- Intercompany contracts
- Managing disruption
- Intangibles
- Remote work
- Operational transfer pricing
- Tariffs
- Dispute resolution and APAs
KPMG LLP's transfer pricing professionals (who are members of our Economic & Valuation Services practice) can help your company deal with transfer pricing challenges. We are supported by global transfer pricing professionals from KPMG International member firms around the world, helping us look beyond borders and understand the nuances of different national regulations.
June 8, 2020 | Download pdf to read more about the transfer issues companies are addressing in today's environment
Webcasts
More insights
Transfer Pricing Substance in Flux - DEMPE, BEPS 2.0, and Covid-19 (July 31, 2020)
Addressing Liquidity Issues during Covid-19 Using Intercompany Pricing Tools (July 20, 2020)
Transfer Pricing Adjustments to the COVID-19 Economic Downturn (July 6, 2020)
COVID-19 Disruption: International Tax and Transfer Pricing Issues (June 29, 2020)
COVID-19's Impact on Transfer Pricing in the Life Sciences Industry (June 29, 2020)
Revisiting Transfer Prices and Intercompany Contracts in Light of COVID-19 (June 22, 2020)
Transfer Pricing Considerations Resulting from COVID-19 (June 8, 2020)
COVID-19 and Transfer Pricing Policy: A Lookback Analysis Of Routine Returns (June 8, 2002)
Advance Pricing Agreements and COVID-19 (May 25, 2020)
Transfer Pricing and Potential Custom Tariff Opportunities in COVID-19 Environment (May 18, 2020)
Covid-19 Disruption in Life Sciences Industry—Tax, Trade, Value Chain Considerations (May 11, 2020)
Intangible Property Transfer Pricing in an Economic Downturn (May 11, 2020)
Transfer Pricing Implications for Intercompany Loans (COVID-19) (May 4, 2020)
COVID-19 Transfer Pricing Strategies for Private Equity Portfolio Companies (April 20, 2020)
Transfer Pricing Implications of COVID-19: Revisiting Pricing, Contracts, and APAs (April 15, 2020)
COVID-19 Puts Limited Risk Structure at Risk (March 26, 2020)
